NORTHWEST BIOTHERAPEUTICS INC Deferred Tax Assets, Operating Loss Carryforwards
NORTHWEST BIOTHERAPEUTICS INC (NWBO) had Deferred Tax Assets, Operating Loss Carryforwards of $236.14 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-04-15
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $236.14M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $222.33M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $211.53M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $202.53M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $236.14M 10-K · filed 2026-04-15 | |
| 2024-12-31 | $222.33M 10-K · filed 2026-04-15 | |
| 2023-12-31 | $211.53M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $202.53M 10-K · filed 2024-03-05 | |
| 2021-12-31 | $193.60M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $185.31M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $176.14M 10-K · filed 2021-03-31 | |
| 2018-12-31 | $170.09M 10-K · filed 2020-03-16 | |
| 2017-12-31 | $153.41M 10-K · filed 2019-04-02 | |
| 2016-12-31 | $204.11M 10-K · filed 2018-04-17 | |
| 2015-12-31 | $180.93M 10-K · filed 2017-04-17 | |
| 2014-12-31 | $133.68M 10-K · filed 2016-03-16 | |
| 2013-12-31 | $99.06M 10-K · filed 2015-03-17 | $99.06K 10-K · filed 2014-04-01 |
| 2012-12-31 | $72.27K 10-K · filed 2014-04-01 | $72.04M 10-K · filed 2013-04-08 |
| 2011-12-31 | $48.18M 10-K · filed 2013-04-08 |